Welcome to Multibagg AI
Log in to access personalized features
IRIS
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Research powered by GOALZEN CAPITAL SERVICES PRIVATE LIMITED · SEBI Research Analyst INH000013448
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
5
Neutral
1
Bullish
8
Bearish
37
Neutral
1
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Bearish
5
Neutral
1
Bullish
8
Bearish
5
Neutral
1
Bullish
8
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Discovery themes featuring this stock
Clean Science and Technology Limited manufactures and exports specialty chemicals from Kurkumbh, Pune, with a focused portfolio including MEHQ, Guaiacol, 4MAP and an expanded HALS series produced principally via its wholly owned subsidiary Clean Fino‑Chem; the company emphasises in‑house catalytic processes, dedicated R&D at each plant, zero liquid discharge facilities and proximity to JNPT for export logistics.
HALS has emerged as a strategic growth engine: management reports HALS at 22% of consolidated sales this quarter, annualised HALS revenue running around INR250–300 crores, and a target of INR300–350 crores incremental revenue from the Geneus collaboration over three to four years, demonstrating a deliberate shift to higher‑grade, higher‑realisation products and improved margin mix.
Financially the company delivered its highest ever consolidated quarterly sales at approximately INR264 crores; consolidated EBITDA was INR96 crores (around 37%) and PAT INR73 crores (around 28%), while standalone reported sequential revenue of INR203 crores with EBITDA and PAT margins of about 43% and 36% respectively, reflecting sustained high profitability despite raw material and supply chain headwinds.
Management emphasised operational resilience: Clean Fino‑Chem has become operationally self‑sustaining after substantial equity infusion, export penetration for HALS increased to nearly 50% of HALS sales this quarter, and multiple new plants (hydroquinone, catechol, Performance Chemical‑2) are being stabilised with commercialisation expected in Q3 FY27, indicating meaningful capacity ramp and product diversification.
Chemicals & Petrochemicals
Specialty Chemicals
7,563 Cr
Moderate Risk
32.5
35.0
1.5
4.8
1,065.35
652.80
Sales CAGR
Profit CAGR
ROE
ROCE
Upcoming Result Date: Oct 30, 2026
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
View Standalone
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
1634.75 | 8,361 Cr | 41.55 | 5.45 | 0.61 | 11.74 | 15.60 | 11.88 | ||
2225.00 | 7,889 Cr | 22.30 | 2.87 | 0.99 | 9.74 | 12.15 | 9.13 | ||
711.55 | 7,563 Cr | 32.47 | 4.78 | 0.84 | 14.50 | 19.52 | 13.06 | ||
2176.90 | 6,540 Cr | 183.91 | 4.15 | 0.08 | 3.52 | 5.24 | 1.23 | ||
1828.15 | 5,923 Cr | 28.11 | 3.00 | 0.60 | 8.46 | 11.24 | 7.68 | ||
479.65 | 5,922 Cr | 61.93 | 3.06 | 0.52 | 5.52 | 7.20 | 3.59 | ||
49.19 | 5,728 Cr | 38.65 | 6.49 | 0.91 | 12.32 | 17.29 | 12.78 | ||
| Median: 7 Co. | — | 1634.75 | 6,540 Cr | 38.65 | 4.15 | 0.61 | 9.74 | 12.15 | 9.13 |
Clean Science & Technology Ltd (CLEAN) is currently trading at 711.55 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Clean Science and Technology Limited manufactures and exports specialty chemicals from Kurkumbh, Pune, with a focused portfolio including MEHQ, Guaiacol, 4MAP and an expanded HALS series produced principally via its wholly owned subsidiary Clean Fino‑Chem; the company emphasises in‑house catalytic processes, dedicated R&D at each plant, zero liquid discharge facilities and proximity to JNPT for export logistics. HALS has emerged as a strategic growth engine: management reports HALS at 22% of consolidated sales this quarter, annualised HALS revenue running around INR250–300 crores, and a target of INR300–350 crores incremental revenue from the Geneus collaboration over three to four years, demonstrating a deliberate shift to higher‑grade, higher‑realisation products and improved margin mix. Financially the company delivered its highest ever consolidated quarterly sales at approximately INR264 crores; consolidated EBITDA was INR96 crores (around 37%) and PAT INR73 crores (around 28%), while standalone reported sequential revenue of INR203 crores with EBITDA and PAT margins of about 43% and 36% respectively, reflecting sustained high profitability despite raw material and supply chain headwinds. Management emphasised operational resilience: Clean Fino‑Chem has become operationally self‑sustaining after substantial equity infusion, export penetration for HALS increased to nearly 50% of HALS sales this quarter, and multiple new plants (hydroquinone, catechol, Performance Chemical‑2) are being stabilised with commercialisation expected in Q3 FY27, indicating meaningful capacity ramp and product diversification.
Over the past 52 weeks, Clean Science & Technology Ltd has traded between a low of ₹652.80 and a high of ₹1,065.35. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Clean Science & Technology Ltd has a market capitalization of approximately 7,562.65. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Clean Science & Technology Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 32.47 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 7,562.65 Cr, Clean Science & Technology Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Clean Science & Technology Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Clean Science & Technology Ltd is 32.47. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
Management cited highest-ever consolidated sales of about INR 264 crore, while published revenue from operations was ₹2,684.32 million, equal to INR 268.432 crore.
Standalone revenue from operations was ₹207.10 crore (-5.8% YoY) and standalone PAT was ₹73.29 crore (-4.3% YoY) for the quarter ended June 30, 2026.
Standalone revenue from operations was ₹207.10 crore and standalone net profit after tax was ₹73.29 crore for the quarter ended June 30, 2026.
It approved unaudited standalone and consolidated results for the quarter and nine months ended December 31, 2025, and declared an interim dividend of ₹2 per share.
